Multiple highly methylated CpG sites as potential epigenetic markers for the diagnosis of prostate cancer
11 July 2025 at 08:00
Prostate cancer (PCa) remains the leading cause of cancer deaths in men. The prostate-specific antigen (PSA) test is widely used for PCa screening, but it lacks specificity and can lead to over-diagnosis and o...